Efficacy and safety of PARP inhibitors in elderly patients with advanced ovarian cancer: a systematic review and meta-analysis | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

other Versions

You are currently viewing an earlier version of this article (October 13, 2022).
View the most recent version of this article

PDF +
Supplementary
Material

Original research

Efficacy and safety of PARP inhibitors in elderly patients with advanced ovarian cancer: a systematic review and meta-analysis

Online download statistics by month:

Online download statistics by month: October 2022 to May 2023

	Abstract	Full	Pdf
Oct 2022	302	310	115
Nov 2022	441	441	101
Dec 2022	214	215	85
Jan 2023	168	170	71
Feb 2023	163	166	75
Mar 2023	95	92	32
Apr 2023	91	89	58
May 2023	72	71	16
Total	1546	1554	553